$1.73 0.11 (+6.79%)
2/13/2012 4:04 PM

K V Pharmaceutical Co. Class A (NYSE:KV-A)

CAPS Rating: 2 out of 5

Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

Recs

0
Player Avatar Gir013 (99.43) Submitted: 6/26/2009 5:34:01 AM : Outperform Start Price: $2.81 KV-A Score: -86.64

Value screener pick, starting to pick up steam after the FDA ruling, up over 60% since I bought it

Report this Post Add Comment

Featured Broker Partners


Advertisement